Actively Recruiting
Study of Symprove Probiotics to Reduce Persistent Gut Symptoms in Adults with Coeliac Disease on a Gluten-Free Diet
Led by Sheffield Teaching Hospitals NHS Foundation Trust · Updated on 2026-03-17
24
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What this Trial Is About
Coeliac Disease CD is a lifelong autoimmune condition where eating gluten causes damage to the small intestine. Although most people improve on a strict gluten-free diet, up to 20% continue to experience gut symptoms like bloating, pain, and diarrhoea even after their intestine has healed. This study evaluates whether a probiotic drink called Symprove, containing live good bacteria, can help relieve these ongoing symptoms by restoring a healthy balance of gut bacteria. Participants will take 70 mL of Symprove orally every day for 3 months, with an optional fourth month if they complete all assessments. Symprove is gluten-free, dairy-free, and contains specific strains of Lactobacillus and Bifidobacterium. This single-arm, open-label study involves self-administration of the probiotic at home to test its effects on gut symptoms and microbiota balance. During the study, participants gut symptoms will be assessed monthly, and their quality of life and gut bacteria diversity will be measured at the start and end of the 3-month period. Stool samples will be collected to analyze gut bacteria changes. The study aims to understand if Symprove can reduce symptoms and improve life for adults with coeliac disease in remission who still have digestive issues.
CONDITIONS
Brief Title
Efficacy of Symprove Probiotics in Coeliac Disease
Research Team
D
David S Sanders, MBChB, MD
A
Arkadeep Dhali, MBBS, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here